X2S1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sinopharm Group Co Ltd

Watchlist Manager

Watchlist

Price: 8.45 EUR -1.74% Market Closed

Market Cap: €5.3B

	Sinopharm Group Co Ltd F:X2S1	CN
	Lemonade Inc LSE:0A91	US
P	Puma SE DUS:PUM	DE
S	Stepan Co F:96S	US
P	Pixelworks Inc XMUN:PXLX	US
	Lineage Cell Therapeutics Inc F:BT3	US

Profitability Summary

Sinopharm Group Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Declining Gross Margin

8% > 7%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

4% > 3%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

2% > 1%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

2% > 2%

Low ROE

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.